![](/img/cover-not-exists.png)
Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease
Dal Molin, Graziela Z, Westin, Shannon N, Coleman, Robert LLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2018-0215
Date:
August, 2018
File:
PDF, 1.36 MB
english, 2018